Brian Wigdahl mainly focuses on Virology, Immunology, Virus, Gene expression and In vitro. His Virology study integrates concerns from other disciplines, such as Disease and Gene. His Virus research is multidisciplinary, incorporating perspectives in Medicinal plants, Long terminal repeat and Drug discovery.
His studies deal with areas such as T cell and Transcription factor, CREB as well as Gene expression. The various areas that he examines in his In vitro study include Vaginal microbicide, Toxicity, Pharmacology, In vivo and Microbicide. His Immune system study which covers Virus latency that intersects with Herpes simplex virus, Antigen, Nucleotide and Molecular biology.
His primary areas of study are Virology, Immunology, Virus, Immune system and Cell biology. The study incorporates disciplines such as Gene expression, Long terminal repeat and Antibody in addition to Virology. His Immunology research incorporates elements of Disease and Microbicide.
His research in Immune system intersects with topics in Proinflammatory cytokine and Cytotoxic T cell. His Cell biology research includes themes of Secretion, Cell culture and T cell. Brian Wigdahl works mostly in the field of Viral replication, limiting it down to concerns involving Transcription and, occasionally, CRISPR and Genetic variation.
Brian Wigdahl mostly deals with CRISPR, Computational biology, Guide RNA, Transcription and Cas9. His CRISPR study incorporates themes from Virology and Provirus. His work on Virus is typically connected to Car t cells as part of general Virology study, connecting several disciplines of science.
His Computational biology research includes elements of DNA and Palindrome. His work deals with themes such as Genetic variation and Cell biology, which intersect with Transcription. Brian Wigdahl works mostly in the field of Cas9, limiting it down to topics relating to DNA sequencing and, in certain cases, Viral quasispecies and In silico.
Brian Wigdahl spends much of his time researching Cas9, CRISPR, Guide RNA, Computational biology and Transcription. His Cas9 research incorporates themes from Genome editing, Virus, Disease and Effector. As part of his studies on CRISPR, he frequently links adjacent subjects like Virology.
His Guide RNA research is multidisciplinary, relying on both Chromatin, DNA, Cleavage and Transcriptome. His research integrates issues of Proviral genome, In silico, DNA sequencing and Viral quasispecies in his study of Computational biology. His research investigates the connection with Transcription and areas like Viral replication which intersect with concerns in Cell biology and Transactivation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cellular Reservoirs of HIV-1 and their Role in Viral Persistence
Aikaterini Alexaki;Yujie Liu;Brian Wigdahl.
Current HIV Research (2008)
CD4-independent infection of human neural cells by human immunodeficiency virus type 1.
J M Harouse;C Kunsch;H T Hartle;M A Laughlin.
Journal of Virology (1989)
Antiviral Potentials of Medicinal Plants
Muhammad Mukhtar;Mohammad Arshad;Mahmood Ahmad;Roger J. Pomerantz.
Virus Research (2008)
Breaking Down the Barrier: The effects of HIV-1 on the Blood-Brain Barrier
Marianne Strazza;Vanessa Pirrone;Brian Wigdahl;Michael R. Nonnemacher.
Brain Research (2011)
HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination
Aikaterini Alexaki;Brian Wigdahl.
PLOS Pathogens (2008)
Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
Kate Barmak;Edward Harhaj;Christian Grant;Timothy Alefantis.
A Broad-Spectrum Microbicide with Virucidal Activity against Sexually Transmitted Viruses
M. K. Howett;E. B. Neely;N. D. Christensen;B. Wigdahl.
Antimicrobial Agents and Chemotherapy (1999)
Human T cell leukemia virus type I and neurologic disease: Events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation
Christian Grant;Kate Barmak;Timothy Alefantis;Jing Yao.
Journal of Cellular Physiology (2002)
Immunological control of herpes simplex virus infections
Kevin P. Egan;Sharon Wu;Brian Wigdahl;Stephen R. Jennings.
Journal of NeuroVirology (2013)
Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate
Fred C Krebs;Shendra R Miller;Daniel Malamud;Mary K Howett.
Antiviral Research (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: